Mumbai, Baltimore, December 21, 2022: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration for its. | December 21, 2022
Lupin Limited today announced that it has received approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for Brivaracetam Tablets.
"The company (Lupin) has received tentative approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Brivaracetam Tablets," Lupin said
Lupin receives tentative U S FDA Approval for Brivaracetam Tablets equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.